VIRAX BIOLABS GROUP LTD (VRAX)

KYG9495L1251 - Common Stock

2.01  +0.07 (+3.61%)

After market: 2 -0.01 (-0.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth

-100.00%		8.56K156.42K
1,727.34%		8.242M
5,169.15%
EBITDA
YoY % growth
N/AN/A-6.003M
-2.67%		-1.003M
83.30%
EBIT
YoY % growth
-1.73M
-170.31%		-5.733M
-231.37%		-6.106M
-6.51%		-1.004M
83.56%
Operating Margin
N/A-66,971.50%-3,903.66%-12.18%
EPS
YoY % growth
N/AN/AN/A
-5.56%		-0.06
68.42%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth		-0.61
68.42%
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth		 79.92K
2,754.29%		%
Q4 2022
Q2Q % growth
-100.00%		%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%